Trial Profile

Compound 451238 and Radiotherapy in Soft-tissue Sarcoma

Status: Active, no longer recruiting

Phase of Trial: Phase I/II

Latest Information Update: 05 Jun 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Compound 451238 (Primary)
Indications Soft tissue sarcoma
Focus Adverse reactions

Most Recent Events

14 Dec 2021 Status changed from recruiting to active, no longer recruiting.
28 Jun 2021 Planned End Date changed from 13 Feb 2022 to 31 Jan 2023.
28 Jun 2021 Planned primary completion date changed from 13 Sep 2020 to 31 May 2022.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com